|
1
|
Feigin VL, Lawes CM, Bennett DA,
Barker-Collo SL and Parag V: Worldwide stroke incidence and early
case fatality reported in 56 population-based studies: A systematic
review. Lancet Neurol. 8:355–369. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sacco RL, Kasner SE, Broderik JP, Caplan
LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD,
Higashida RT, et al: An updated definition of stroke for the 21st
century: A statement for healthcare professionals from the American
heart association/American stroke association. Stroke.
44:2064–2089. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liu L, Wang D, Wong KS and Wang Y: Stroke
and stroke care in China: Huge burden, significant workload, and a
national priority. Stroke. 42:3651–3654. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Feigin VL, Roth GA, Naghavi M, Parmar P,
Krishnamurthi R, Chugh S, Mensah GA, Norrving B, Shiue I, Ng M, et
al: Global burden of stroke and risk factors in 188 countries,
during 1990-2013: A systematic analysis for the global burden of
disease study 2013. Lancet Neurol. 15:913–924. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liang C, Ni G, Ma J, Liu H, Mao Z, Sun H
and Zhang X: Impact of tag single nucleotide polymorphisms (SNPs)
in CCL11 gene on risk of subtypes of ischemic stroke in Xinjiang
Han populations. Med Sci Monit. 23:4291–4298. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bersano A, Ballabio E, Bresolin N and
Candelise L: Genetic polymorphisms for the study of multifactorial
stroke. Hum Mutat. 29:776–795. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Huen K, Yousefi P, Street K, Eskenazi B
and Holland N: PON1 as a model for integration of genetic,
epigenetic, and expression data on candidate susceptibility genes.
Environ Epigenet. 1(dvv003)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang Z, Xu G, Liu D, Fan X, Zhu W and Liu
X: Angiotensin-converting enzyme insertion/deletion polymorphism
contributes to ischemic stroke risk: A meta-analysis of 50
case-control studies. PLoS One. 7(e46495)2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tuncer N, Tuglular S, Kılıç G, Sazci A, Us
O and Kara I: Evaluation of the angiotensin-converting enzyme
insertion/deletion polymorphism and the risk of ischaemic stroke. J
Cli Neurosci. 13:224–227. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pera J, Slowik A, Dziedzic T, Wloch D and
Szczudlik A: ACE I/D polymorphism in different etiologies of
ischemic stroke. Acta Neurol Scand. 114:320–322. 2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu J, Sun K, Bai Y, Zhang W, Wang X, Wang
Y, Wang H, Chen J, Song X, Xin Y, et al: Association of three-gene
interaction among MTHFR, ALOX5AP and NOTCH3 with thrombotic stroke:
A multicenter case-control study. Hum Genet. 125:649–656.
2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Arina CA, Amir D, Siregar Y and Sembiring
RJ: The Role of polymorphism gen methylene tetra hydrofolate
reductase (MTHFR) C677T in ischaemic stroke patients with and
without hypertension. Open Access Maced J Med Sci. 7:29–32.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Coen Herak D, Lenicek Krleza J, Radic
Antolic M, Horvat I, Djuranovic V, Zrinski Topic R and Zadro R:
Association of polymorphisms in coagulation factor genes and
enzymes of homocysteine metabolism with arterial ischemic stroke in
children. Clin Appl Thromb Hemost. 23:1042–1051. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kopyta I, Niemiec P, Balcerzyk A,
Emich-Widera E, Pilarska E, Pienczk-Ręcławowicz K, Kaciński M,
Wendorff J, Nowak T, Iwanicki T, et al: Fibrinogen alpha and beta
gene polymorphisms in pediatric stroke-case-control and family
based study. Eur J Paediatr Neurol. 19:176–180. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kumar A, Misra S, Kumar P, Sagar R and
Prasad K: Association between beta-fibrinogen C148T gene
polymorphism and risk of ischemic stroke in a north Indian
population: A case-control study. Pulse (Basel). 4:165–171.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hu X, Zan X, Xie Z, Li Y, Lin S, Li H and
You C: Association between plasminogen activator inhibitor-1
genetic polymorphisms and stroke susceptibility. Mol Neurobiol.
54:328–341. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Eriksson P, Kallin B, Van't Hooft FM,
Båvenholm P and Hamsten A: Allele-specific increase in basal
transcription of the plasminogen-activator inhibitor 1 gene is
associated with myocardial infarction. Proc Natl Acad Sci USA.
92:1851–1855. 1995.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Iacoviello L, Burzotta F, Di Castelnuovo
A, Zito F, Marchioli R and Donati MB: The 4G/5G polymorphism of
PAI-1 promoter gene and the risk of myocardial infarction: A
meta-analysis. Thromb Haemost. 80:1029–1030. 1998.PubMed/NCBI
|
|
19
|
Jood K, Ladenvall P, Tjärnlund-Wolf A,
Ladenvall C, Andersson M, Nilsson S, Blomstrand C and Jern C:
Fibrinolytic gene polymorphism and ischemic stroke. Stroke.
36:2077–2081. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wiklund PG, Nilsson L, Ardnor SN, Eriksson
P, Johansson L, Stegmayr B, Hamsten A, Holmberg D and Asplund K:
Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of
stroke: Replicated findings in two nested case-control studies
based on independent cohorts. Stroke. 36:1661–1665. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mahley RW and Rall SC Jr: Apolipoprotein
E: Far more than a lipid transport protein. Annu Rev Genomics Hum
Genet. 1:507–537. 2000.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pezzini A, Grassi M, Del Zotto E, Bazzoli
E, Archetti S, Assanelli D, Akkawi NM, Albertini A and Padovani A:
Synergistic effect of apolipoprotein E polymorphisms and cigarette
smoking on risk of ischemic stroke in young adults. Stroke.
35:438–442. 2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sturgeon JD, Folsom AR, Bray MS,
Boerwinkle E and Ballantyne CM: Atherosclerosis Risk in Communities
Study Investigators. Apolipoprotein E genotype and incident
ischemic stroke: The aherosclerosis rsk in cmmunities sudy. Stroke.
36:2484–2486. 2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chinese Neurology Association. Chinese
guidelines for the diagnosis and treatment of acute ischemic stroke
in 2014. Chin J Neurol. 48:246–257. 2015.
|
|
25
|
Murray CJ and Lopez AD: Measuring the
global burden of disease. N Engl J Med. 369:448–457.
2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Beal CC: Gender and stroke symptoms: A
review of the current literature. J Neurosci Nurs. 42:80–87.
2010.PubMed/NCBI
|
|
27
|
Fluri F, Schuhmann MK and Kleinschnitz C:
Animal models of ischemic stroke and their application in clinical
research. Drug Des Devel Ther. 9:3445–3454. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li G, Liu Y, Li X, Ning Z, Sun Z, Zhang M,
Lu Y, Wu L and Wang L: Association of PAI-1 4G/5G polymorphism with
ischemic stroke in Cinese patients with type 2 diabetes mellitus.
Genet Test Mol Biomarkers. 22:554–560. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhao LL, Su G, Chen LX, Yan Q, Wang XP,
Yuan W, Wang L and Zhang ZC: Apolipoprotein E polymorphisms are
associated with ischemic stroke susceptibility in a Northwest China
Han population. Biosci Rep. 37(BSR20171088)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lin CC, Yang CP, Li CI, Liu CS, Chen CC,
Lin WY, Hwang KL, Yang SY and Li TC: Visit-to-visit variability of
fasting plasma glucose as predictor of ischemic stroke: Competing
risk analysis in a national cohort of Taiwan diabetes study. BMC
Med. 12(165)2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lee JS, Chang PY, Zhang Y, Kizer JR, Best
LG and Howard BV: Triglyceride and HDL-C dyslipidemia and risks of
coronary heart disease and ischemic stroke by glycemic
dysregulation status: The strong heart study. Diabetes Care.
40:529–537. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhao J, Qin X, Li S and Zeng Z:
Association between the ACE I/D polymorphism and risk of ischemic
stroke: An updated meta-analysis of 47,026 subjects from 105
case-control studies. J Neuro Sci. 345:37–47. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wu G, Cai H, Cai H, Chen Z, Tan L, Qi H
and Cai Y: Effect of the-148C/T, 448G/A, and -854G/A polymorphisms
of the β-fibrinogen gene on the risk of ischemic stroke in Chinese
population. J Stroke Cerebrovasc Dis. 24:1577–1590. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Anderson RE, Tan WK, Martin HS and Meyer
FB: Effects of glucose and PaO2 modulation on cortical
intracellular acidosis, NADH redox state, and infarction in the
ischemic penumbra. Stroke. 30:160–170. 1999.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kawai N, Keep RF and Betz AL:
Hyperglycemia and the vascular effects of cerebral ischemia.
Stroke. 28:149–154. 1997.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Dietrich WD, Alonso O and Busto R:
Moderate hyperglycemia worsens acute blood-brain barrier injury
after forebrain ischemia in rats. Stroke. 24:111–116.
1993.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Pawelczyk M, Kaczorowska B and Baj Z: The
impact of hyperglycemia and hyperlipidemia on plasma P-selectin and
platelet markers after ischemic stroke. Arch Med Sci. 13:1049–1056.
2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Nomura S, Inami N, Iwasaka T and Liu Y:
Platelet activation markers, microparticles and soluble adhesion
molecules are elevated in patients with arteriosclerosis
obliterans: Therapeutic effects by cilostazol and potentiation by
dipyridamole. Platelets. 15:167–172. 2004.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Powers WJ, Rabinstein AA, Ackerson T,
Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk
BM, Hoh B, et al: 2018 Guidelines for the early management of
patients with acute ischemic stroke: A guideline for healthcare
professionals from the American heart association/American stroke
association. Stroke. 49:e46–e110. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Li YY: Plasminogen activator inhibitor-1
4G/5G gene polymorphism and coronary artery disease in the Chinese
Han population: A meta-analysis. PLoS One. 7(e33511)2012.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Guney AI, Ergec D, Kirac D, Ozturhan H,
Caner M, Koc G, Kaspar C, Ulucan K and Agirbasli M: Effects of ACE
polymorphisms and other risk factors on the severity of coronary
artery disease. Genet Mol Res. 12:6895–6906. 2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Suzuki T, Yokota H, Yamazaki T, Kitamura
K, Yamaoki K, Nagai R and Yazaki Y: Angiotensin converting enzyme
polymorphism is associated with severity of coronary heart disease
and serum lipids (total cholesterol and triglycerides levels) in
Japanese patients. Coron Artery Dis. 7:371–375. 1996.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lee YJ and Tsai JC: ACE gene
insertion/deletion polymorphism associated with 1998 world health
organization definition of metabolic syndrome in Chinese type 2
diabetic patients. Diabetes Care. 25:1002–1008. 2002.PubMed/NCBI View Article : Google Scholar
|
